Načítá se...
Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era
Atrial fibrillation (AF) is a major cause of ischaemic stroke. The majority of these strokes can be prevented by treatment with oral anticoagulation therapy. The advent of non-vitamin K antagonist oral anticoagulants (NOACs) has resulted in a choice of therapeutic agents available to physicians for...
Uloženo v:
| Vydáno v: | Ther Adv Chronic Dis |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692140/ https://ncbi.nlm.nih.gov/pubmed/29201334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622317720106 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|